Quince Therapeutics (QNCX) Q3 2023 Earnings

14NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.31
-0.21
-0.1
0

Details

Expected EPS
N/A
Actual EPS
-0.15
Surprise EPS
-0.15
Surprise Percent
+∞%

Description

Quince Therapeutics (QNCX) has reported earnings of -0.15 per share for Q3 2023.

0 Comments

Share your thoughts